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Biochemistry and Biophysics, Stockholm University, Stockholm, SwedenABSTRACT Improving our understanding of the mechanisms and effects of anesthetics is a critically important part of neuro-
science. The currently dominant theory is that anesthetics and similar molecules act by binding to Cys-loop receptors in the post-
synaptic terminal of nerve cells and potentiate or inhibit their function. Although structures for some of the most important
mammalian channels have still not been determined, a number of important results have been derived from work on homologous
cationic channels in bacteria. However, partly due to the lack of a nervous system in bacteria, there are a number of questions
about how these results relate to higher organisms. The recent determination of a structure of the eukaryotic chloride channel,
GluCl, is an important step toward accurate modeling of mammalian channels, because it is more similar in function to human
Cys-loop receptors such as GABAAR or GlyR. One potential issue with using GluCl to model other receptors is the presence of
the large ligand ivermectin (IVM) positioned between all five subunits. Here, we have performed a series of microsecond mo-
lecular simulations to study how the dynamics and structure of GluCl change in the presence versus absence of IVM. When
the ligand is removed, subunits move at least 2 A˚ closer to each other compared to simulations with IVM bound. In addition,
the pore radius shrinks to 1.2 A˚, all of which appears to support a model where IVM binding between subunits stabilizes an
open state, and that the relaxed nonIVM conformations might be suitable for modeling other channels. Interestingly, the pres-
ence of IVM also has an effect on the structure of the important loop C located at the neurotransmitter-binding pocket, which
might help shed light on its partial agonist behavior.INTRODUCTIONPentameric ligand-gated ion channels (pLGICs) constitute
an important superfamily of ion channels, both for their
paramount role in the central nervous system and because
they interact with many allosteric ligands. These properties
make them interesting targets for the pharmaceutical indus-
try. Surprisingly, pLGICs appear to be of prokaryotic origin
(1), despite the lack of nervous system in these organisms.
In eukaryotes, pLGICs are located in the postsynaptic termi-
nal of nerve cells and are responsible for fast neurotransmis-
sion. Metazoan pLGICs, unlike their prokaryotic homologs,
exhibit a disulfide bridge stabilizing a loop near the extracel-
lular domain (ECD), and are therefore often referred to as
Cys-loop receptors. Two early low-resolution structures of
torpedo nicotinic acetylcholine receptor were reported by
Unwin and co-workers using cryo-electron microscopy
(2,1). In addition, there are now x-ray structures of pLGICs
for prokaryotic channels; ELIC (closed) (4) and GLIC
(open) (5,6). GLIC, in particular, has been an exceptionally
good pLGIC testbed for experiments, models, and simula-
tions. All pLGICs subunits share a common topology with
four helical segments forming a transmembrane domain
(TMD), connected to an extracellular beta sandwich domain
(ECD). Five such subunits form a channel, with the secondSubmitted April 19, 2013, and accepted for publication June 25, 2013.
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The neurotransmitter-binding site is located in the ECD, be-
tween subunits (7). It is surrounded by loops A-B-C from
one (principal) subunit and loops D-E-F from its neighbor
(auxiliary) subunit. Loop C is located at the principal side
and isolates the neurotransmitter-binding pocket from the
surroundings. It is a short loop, including small portions
of the b9 and b10 strands. Previous studies have reported
conformational changes of loop C upon binding of agonists.
When an agonist is bound to the neurotransmitter pocket,
loop C closes around the ligand, whereas antagonist binding
leads to loop C adopting an uncapped conformation and
swinging outward (8–11).
One potential problem for homology modeling of LGICs
is that the current prokaryotic structures are all cationic
channels, similar to the nicotinic acetylcholine receptor,
although many of the most important receptors for anes-
thetics and alcohol research (in particular GABAAR and
GlyR) are anionic channels (11–13). The latter have
roughly 30% sequence identity to their prokaryotic homo-
logs, but because they have virtually opposite potentiation
and inhibition patterns, it is not trivial to model wide
ranges of eukaryotic channels based on the prokaryotic
structures. To further complicate the situation, drugs such
as alcohol or anesthetics somewhat surprisingly do not
bind in the neurotransmitter-binding site in the ECD, but
act as allosteric modulators that interact with the TMD.http://dx.doi.org/10.1016/j.bpj.2013.06.037
Simulations of GluCl with Ivermectin 641At least three binding pockets have been identified in
LGICs; one located between subunits in the ECD, and
two others located in the TMD, within and between sub-
units, respectively (12). Not all channels exhibit all these
sites and recent results support the idea of separate poten-
tiating and inhibitory sites (14,15), but also point to impor-
tant differences between prokaryotic and eukaryotic
channel modulation (16).
Until recently, no x-ray structures were available for any
eukaryotic LGIC, but this changed with the GluCla struc-
ture (17). In theory, this structure should facilitate studies
of human channels such as GABAAR and GlyR, because
GluCla is both eukaryotic and anionic. However, the Glu-
Cla channel in the x-ray structure is stabilized in the open
state by the bound ligand ivermectin (IVM). IVM is a
widely used drug against parasites and arthropods; it is a
semisynthetic macrocyclic lactone, derived from Strepto-
myces avemitilis. IVM binds to GABAAR and GlyR at
high micromolar concentrations (18,19) and to GluCl at
nanomolar concentrations (20). As revealed in the crystal
structure, IVM appears to act by binding in the intersubunit
pocket in the TMD. It locks the channel in a state that facil-
itates further activation by ligands like glutamate and is
therefore considered a partial agonist. However, the large
size of IVM also means the molecule is likely to affect
the relative positions of subunits and their interactions,
which could complicate homology modeling of other chan-
nels such as GABAAR or GlyR based on GluCl.
Molecular dynamic studies, in particular, can address this
issue andmay even be able to generate a stablemodelwithout
any ligands attached. Therefore, we have used microsecond
molecular dynamics simulations to compare the behavior
of GluCl in the absence versus presence of IVM.As proposed
by Hibbs et al. (17), binding of IVM does indeed increase
the intersubunit distance and stabilizes the channel in an
open conformation. Furthermore, it appears to induce new
conformational changes at the loops located at the neuro-
transmitter-binding pocket, which might help explain its
partial agonist behavior. In the absence of IVM, the allosteric
modulator site undergoes a rather striking change with sub-
units becoming closer together, which in turn decreases the
pore radius and tends toward a more closed state.METHODS
The Protein Data Bank (PDB) x-ray structure of GluCla cocrystallized with
IVM (PDB ID 3RWH) was used. The Amber99SB-ILDN force field was
used for the protein (21). Parameters for IVM were generated and added
to the force field by determining atom and bond types with Antechamber
(22). Point charges were calculated from quantum chemistry; a semiempir-
ical PM3 Hamiltonian was used to find a local energy minimum conforma-
tion for the ligand and a Hartree-Fock HF/6-31G(d) basis set employed to
calculate the electrostatic potential in combination with a self-consistent re-
action field (23) and an integral equation formalism using 78.39 (water) as
the external dielectric constant with a polarizable continuum model. All
such calculations were undertaken with GAUSSIAN 03 (24). The pointcharges were determined from the electrostatic potential with the RESP
model (25).
Structures with and without IVM were prepared independently, and in-
serted into previously relaxed DOPC (1,2-dioleoyl-sn-3-phosphatidylcho-
line) lipid bilayer systems modeled with the Berger force field
parameters (26). After removal of overlapping lipids each system contained
304 DOPC lipids and ~32,500 waters in a hexagonal box with a side of
11.2 nm and height of 15.2 nm. 59 Naþ anions and 69 Cl cations were
added to neutralize the system and achieve a realistic salt concentration
around 100 mM.
The system without IVM was minimized for 10,000 steps excluding
protein-protein nonbonded interactions, and then relaxed in a series of
three 5 ns simulations with position restraints (1000 kJ/mol/nm2) applied
first to all heavy atoms, and then protein backbone, and finally only Ca
atoms.
The system with IVM was minimized similarly for 5000 steps, and then
another 10,000 steps including all interactions. To better relax protein-IVM
interactions, the initial position restraint simulation was extended to 50 ns
(all IVM atoms constrained), followed by 10 ns simulations where the pro-
tein backbone and IVM heavy atoms were restrained, and finally 10 ns of
Ca atoms restraints (IVM unrestrained).
All simulations were run with Gromacs 4.5, using the LINCS algorithm
(27) to constrain all bond lengths and 2–2.5 fs time steps. Particle mesh
Ewald electrostatics was used with a 10 A˚ cutoff. For both systems, protein,
water and ions, lipids, as well as IVM were coupled separately to temper-
ature baths of 310 K using the Bussi velocity rescaling thermostat (28) and a
constant of tT ¼ 0.1ps. Pressure was adjusted with a semiisotropic Berend-
sen weak barostat to a pressure of 1 bar with tP ¼ 5 ps and compressibility
4.5  105 bar1. No constraints were applied to either the protein or IVM
in production runs.
The binding pocket volume was analyzed using Mdpocket from the
fpocket suite (29). A reference grid was computed from the crystal
structure, using only two subunits for both the extracellular and transmem-
brane binding pockets. This grid was then superimposed on all five sub-
units. Mdpocket was run with default parameters except that 5,000
Monte Carlo iterations were used instead of 2,500. The pore radius was
computed using the HOLE (30) software on frames extracted every nano-
second and the computed radius was averaged over 100 ns windows. Fig-
ures illustrating the pore radius were generated with VMD (31) and the
remaining with PyMol (32).RESULTS
Removal of IVM decreases the intersubunit
distances at the EMD-TMD interface
To study the distance between subunits, we monitored the
distance between Ca atoms of residues G281 in helix M3
and L218 in helix M10 for each pair of adjacent subunits
(prime notion on segments denote the next subunit). In the
GluCla crystal structure (with IVM present) this distance
amounts to 9.4 A˚, although it is substantially shorter
(6.4 A˚) for the corresponding atoms in GLIC (17). For the
GluCl simulation where IVM was kept between all five sub-
units, this 9.4 A˚ distance was maintained throughout the
simulation, within statistical errors. However, for the simu-
lation where IVMwas removed, the M3-M10’ distance drop-
ped to ~7.5 A˚, and still appeared to be decreasing after 1 ms.
(Fig. 1). These residues (M3-G281 in M10-L218) are located
at the extracellular part of the TMD and directly adjacent to
the pocket where IVM binds. To study the spacing of the M3
and M10 segments further down in the TMD, we calculatedBiophysical Journal 105(3) 640–647
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FIGURE 1 IVM removal brings subunits together. In the absence of IVM
(IVM), the M3 and M10 helices in adjacent GluCl subunits moved from
9.5 A˚ to 7.5 A˚; a distance close to the TMD-ECD interface (solid thick),
compared to a virtually constant distance with IVM (þIVM). The motion
was much less pronounced further down in the structure (dashed thick).
A similar, but smaller, difference was present between the M2 and M10 he-
lices (thin lines).
FIGURE 2 The allosteric site volume drops without IVM. Top: After
IVM was removed, side chains and lipid tails occupied the binding pocket,
and the helices moved closer together. The upper left panel shows the final
structure after 1 ms of simulation with IVM, whereas the right side is the
corresponding structure without IVM. The x-ray structure is shown as trans-
parent gray. IVM coordinating residues are shown as sticks. Bottom: The
volume of the allosteric modulator site stayed similar to the starting crystal
structure (cAMS) with IVM (þAMS) bound, whereas it dropped to less
than half its initial size when IVM was removed (AMS). In contrast,
the volume of the neurotransmitter-binding pocket (NBP) was similar to
the starting crystal structure (cNBP) with or without IVM present
(þNBP,NBP).
642 Yoluk et al.the distance between residues L292 and V233. Interestingly,
this distance is quite stable at 7.2 A˚ both in the presence and
absence of IVM. It is close to the corresponding value in
GLIC (7.6 A˚), which indicates the subunit motion is more
localized to the extracellular region of the TMD. Removal
of IVM not only affects the M3-M10 distance, but also the
distance between M2 and M10. The distance between resi-
dues M2-S260 and M10-Q219 located at the extracellular
part of the TMD exhibited at least one large increase in
the presence of IVM, whereas the distance between residues
M2-T257 and M10-L227 was similar in both simulations
(Fig. 1).
The reduction in intersubunit distances in the absence
of IVM was not coupled to corresponding increases in
intrasubunit distances; the latter remained stable in both
simulations with an exception of the M1-M2 distance
close to the TMD-ECD interface (Fig. S1 in the Supporting
Material). The secondary structure fluctuations in M2
close to the TMD-ECD interface might have a role in the
large M1-M2 distance shifts, both inside and between
subunits.
These findings support the conclusion that IVM has a
large effect on the stability of the TMD closer to the ECD
interface, whereas the rest of the TMD preserves its confor-
mation (Fig. 1, Fig. S1). In addition, the largely constant dis-
tances inside subunits suggest that the motion is mainly
entire subunits moving closer and inward rather than indi-
vidual helices changing conformations.Biophysical Journal 105(3) 640–647The intersubunit-binding pocket is smaller
without IVM
IVM binds to the intersubunit-binding pocket of GluCl,
similar to the site where we have previously identified bind-
ing sites for anesthetics and alcohols in GlyR (14) and GLIC
(15,16). When the IVM ligand is removed before equili-
brating the structure, this pocket rapidly shrinks due to occu-
pation by protein side chains and lipid tails. Lipid tails
occupy ~4 out of 5 pockets simultaneously, and 90% of
the time, at least one binding pocket is occupied by lipid
tails (Fig. S4). The pocket volume in the crystal structure
was roughly 700 A˚3, after equilibration it dropped to
~350 A˚3, and during the microsecond production simulation
it was reduced even further to reach ~250 A˚3 (Fig. 2). The
occupation of the binding pocket by the lipids was rather dy-
namic and no correlation between the volume and the occu-
pancy was observed. The latter volume is close to that
estimated for an anesthetic binding site using site-directed
mutagenesis (33). This decrease in volume was mainly
due to protein backbone motion; in particular, related to
the shorter intersubunit distances as described previously.
Simulations of GluCl with Ivermectin 643When IVM was kept in the structure, the same binding
pocket preserved its initial size throughout the simulation
with only minor fluctuations (Fig. 2).
Although there was a clear effect on the allosteric binding
pocket, the volume of the neurotransmitter-binding pocket
was unaffected and remained around 270 A˚3 in simulations
both with and without IVM (Fig. 2). Because IVM is a par-
tial agonist, this result could support a mechanism where
IVM mainly facilitates (or possibly partially induces) the
conformational change in the TMD.D
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FIGURE 3 IVM allows the GluCl pore to be more open at 90. Although
the pore is mostly dehydrated after relaxation at the 90 region, the presence
of IVM allowed the channel to sample slightly higher radii, with an average
of 1.45 0.2 A˚, compared to the simulation without IVM, where the mean
was 1.25 0.2 A˚. Due to very long correlations, it is not trivial to translate
standard deviations to standard errors of means, but using a Welch t-test the
difference between the two distributions was found to be statistically signif-
icant. The box plot in the inset indicates the first, median, and third quartiles
in each box, and whiskers for the smallest/largest values that still are within
a factor 1.5 of the box quartiles. Outliers beyond the whiskers are shown as
circles.The pore appears to sample more open
conformations with IVM
In the GluCl crystal structure, IVM makes 3 H-bonds within
each intersubunit cavity, one of which is with S260 (150 po-
sition in the M2 helix). The pore radius in the open GluCl
structure is somewhat similar to the presumed-open confor-
mation of GLIC (17). In contrast, the recent locally closed
structures of GLIC (34) differ from the open state around
the 90 and 160 locations in M2, where the pore is in a
more closed conformation, similar to the structure of
ELIC captured in a closed state (4,6). The presence of
IVM in our simulations of GluCl had an effect on the pore
conformation starting from 140 all the way up to the ECD.
With IVM present, the channel appeared to explore more
open conformations; as open as the GluCl and GLIC crystal
structures. On the other hand, in the absence of IVM, the
channel rather primarily visits more closed states, but at
least in these microsecond-scale simulations the conforma-
tions were not quite as closed as the locally closed GLIC
structures or ELIC (Fig. S2). Nevertheless, this change
clearly supports the assumption that IVM also had an effect
on the M2 helices close to the ECD interface by pushing the
entire subunits apart and away from the central pore axis to
make the channel favor more open conformations.
IVM does not only keep GluCl more open around the 160
region, but it also causes the channel to be slightly more open
at the 90 region. Both in the simulations with and without
IVM, the smallest radius occurred around the 90 position,
where the conformation was as closed as ELIC (Fig. S2).
For a small fraction (0.8%) of the simulation with IVM pre-
sent, the minimum radius shifted to a lower part of the chan-
nel (Fig. S5). No such shift was observed without IVM.
Partial dehydration or collapse of the pore has been observed
in a number of previous simulations of ligand-gated ion
channels (35,14,36), but interestingly this behavior too ap-
pears to depend on the absence or presence of IVM. In the
presence of IVM, the channel still explored more open con-
formations periodically; after the first 100 ns the minimum
radius was ~2.3 A˚. In contrast, when IVM was removed,
the minimum radius was only ~1.7 A˚, without any periodic
increases. Although the minimum pore radius average was
closer in the two simulations (1.4 A˚ with IVM, 1.2 A˚
without), their relative difference was found to be statisti-cally significant with a two-tailed Welch t-test. Both the
average and tail values of the radius were clearly shifted to-
ward a more open pore due to IVM being bound (Fig. 3).
In the presence of IVM, the channel appeared to fluctuate
between an open state and one slightly more closed
compared to the open GLIC and GluCla crystal structures.
Without IVM bound, the channel moved toward more
closed states, although it does not appear to reach as far as
the locally closed structures of GLIC at the 160 region in
1 ms (Fig. 3, Fig. S2).IVM causes conformational changes in loop C
The partial agonist properties of IVM make it interesting to
study its influence on the ECD in more detail. As reported
previously, there was no significant effect on the volume
of the neurotransmitter-binding pocket volume, but calcula-
tion of the root mean-square displacement (RMSD) of Ca
coordinates in the ECD indicated higher values at certain
time points, e.g., around 250 ns. Average root mean-square
fluctuations plotted as a function of residue revealed that the
differences in the ECD mainly occurred in the loop regions.
These were more flexible in the absence of IVM, and the
highest fluctuations were observed for residues from S193
to C202, or loop C.Biophysical Journal 105(3) 640–647
644 Yoluk et al.In both simulations, a small swing-like motion was
observed in loop C, where it moved outward from the cen-
tral channel axis, but there was a difference in the conforma-
tions visited in the presence of IVM. In the x-ray structure of
GluCl, loop C is relatively well ordered, partly because the
antibody used during crystallization binds to this region of
the surface. However, without the antibody present, short
portions of the b9 and b10 strands that are part of loop C
lost their secondary structure and turned into coil. This
behavior was first observed in one subunit starting at
~170 ns (Fig. 4) and this part of the subunit stayed in a disor-
dered state throughout the remainder of the microsecond
simulation. Two more subunits started to exhibit gradual
fluctuations of the secondary structure in this region, until
loop C was finally in a fully disordered state (Fig. 4, top
left). In comparison, without IVM present, there were only
small motions in loop C (Fig. 4, top right).
Considering that the original structure was obtained with
IVM bound, it is interesting that the removal of this ligand
leads to increased rather than reduced ordering in the loop
C part of the structure, in particular when this loop sur-
rounds the neurotransmitter-binding pocked. When it loses
its ordered structure, loop C exposes a pocket that is more
open to the surroundings. This outward motion of Loop C
might explain the partial agonist behavior, and why the
modulation of GluCla and GluClb differs (37). That is,FIGURE 4 Loop C is more flexible with IVM bound in TMD. Loop C is
located next to the neurotransmitter site, almost 40 A˚ away from the allo-
steric site. IVM binding still caused loop C to lose beta sheet structure in
three subunits (top left), whereas all subunits stayed intact in the absence
of IVM (top right). RMSD calculations (bottom) showed that the C loops
were mostly rigid throughout the simulations without IVM, but distorted
when the ligand was bound. Each color in the two top panels corresponds
to a snapshot from each simulation (extracted every 100 ns).
Biophysical Journal 105(3) 640–647the difference in the composition (e.g., hydrophobicity)
and length of Loop C in the beta subunit might allow it to
be in a disordered state, whereas the alpha subunit would
need IVM bound to adopt this state.IVM disrupts interactions between subunits
The presence of IVM clearly increases the distance between
subunits (partly for simple steric reasons), but considering
that much smaller molecules, such as ethanol, also act in
this region for many channels, it is an interesting question
to what extent it affects the interactions between subunits.
The number of H-bonds between subunits increased
slightly during the simulation, and there were roughly 1–2
more H-bonds after IVM was removed (Fig. 5). This is
partly due to the interactions between the M10 helix and
the adjacent subunit. Side chains of residues L218 to
Y221 had fewer H-bonds to the adjacent subunit in the pres-
ence of IVM (Fig. S3), and IVM took over some of the dis-
rupted interactions between subunits.
In the crystal structure, IVM participates in three
H-bonds: with the backbone of L218, and the side chains
of S260 and T285. The H-bond with the backbone was
conserved throughout the simulation, whereas the interac-
tions with the side chains were more dynamic. On average,
only one of the H-bonds was fulfilled at any time in the
simulation. Residues involved in the H-bonds were located
at M10 (Q219), M2 (S260, N264), and M3 (T285) (Fig. 2).4
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FIGURE 5 IVM disrupts hydrogen bonds between subunits. Top: The
number of hydrogen bonds between each pair of adjacent subunits was
1–2 lower in the presence (black) compared to the absence (red) of IVM.
The difference appeared to stabilize at roughly one H-bond after 1 ms of
simulation, and was mainly due to interactions with M1 (see Fig. S3).
Although the hydrogen bonds between subunits were disrupted, IVM
formed new hydrogen bonds with the side chains of residues 219, 260,
264, and 285 (IVM-SCh). The hydrogen bond between the main chain of
residue 218 and IVM was conserved throughout the simulation
(IVM-MCh).
Simulations of GluCl with Ivermectin 645Residues S260 and N264 were competing to interact with
IVM. S260 is thought to be important for the activity of
the IVM, as GluClb does not have a serine residue at this po-
sition and it is not activated by IVM (37). On the other hand,
GlyR and GABAAR have a serine residue at this position
and are activated by IVM at micromolar concentrations.
GluClb has an aspargine residue at the same position as res-
idue 264, whereas GlyR and GABAAR have an arginine.
The presence of an amide or acidic residue at position 180
might be important to facilitate IVM binding, which then
would explain the required high concentrations of IVM on
GlyR and GABAAAR. The interaction of IVM is weaker
with GlyR and GABAAR because there is only one residue
for IVM to have an H-bond to (S260), although residue 264
cannot act as an H-bond acceptor when it is an arginine.
No H-bonds were observed to the M2-M3 loop, except
short-lived contacts to residue S271, meaning that IVM
gets close enough to compete with native protein interac-
tions with the M2-M3 loop. However, the stabilization of
the open state might not be due to H-bonds with this partic-
ular loop; some other interactions were proposed by Hibbs
and Gouaux (17).DISCUSSION
Although the size of IVM might complicate homology
modeling, the strong effect of the ligand makes it a good
testbed to understand how the allosteric ligand influences
the pore, the binding pocket, the interactions between sub-
units, and the other structural elements such as loop C.
Both the x-ray structure (with IVM) and a conformation
where the ligand had been removed were stable over a
microsecond of simulation, but there were a number of dif-
ferences in behavior. In particular, the presence of IVM led
to an intersubunit distance of ~9.4 A˚, whereas it was ~7.5 A˚
without the ligand bound (Fig. 1). This mechanism is likely
to be general, because the IVM binding pocket in the TMD
is also one of the sites where anesthetics are thought to bind
in GlyR or GABAAR. This intersubunit distance change was
limited to the upper part of the TMD, which is the same re-
gion exhibiting a significant change between the open and
locally closed forms of the GLIC channel (34). A common
concern for all models using the GluCl-IVM structure is that
the removal of IVM will cause a collapse of the intersubunit
pocket and allow M3-M10 helices to move closer (Fig. 2).
This means that homology models would also likely have
to go through the same structural change before reaching
a more natural conformation for the protein (Fig. 1). Pres-
ently, it is difficult to say how severe this would be, e.g.,
for packing of side chains between subunits in homology
models.
The overall RMSD of the TMD did not exhibit any signif-
icant differences between the simulations with/without
IVM, which supports the hypothesis that the effects are local
and easily drown in the fluctuations over five subunits. Incontrast, the shrinking intersubunit pocket volume was a
direct and clear effect caused by M3-M10 helices moving
closer, lipids entering the pocket, and side-chain reorienta-
tion. After 1 ms without IVM, the volume of the pocket
was less than half of its initial value and the M3-M10 helices
were 2 A˚ closer. The distance was still shrinking after 1 ms,
and with a longer simulation it might very well reach the
same separation as observed in locally closed GLIC
(6.5 A˚, which requires another 1 A˚ decrease). Now, on bal-
ance, there are also issues with extending simulations to
relax the structure without IVM, because this would eventu-
ally lead to a completely closed structure rather than an open
one (which might not be the target for a homology model).
In this context, it is worth considering that pore dehydra-
tion occurs frequently in simulations, which sometimes has
been suggested to be channel closure. Several previous
studies have reported on a dehydrated pore around the 90 re-
gion, even when open state crystal structures have been used
as starting points (14,35,36). One possible explanation
could be the use of imperfect protonation states in simula-
tions. Because it is not possible to determine the protonation
states from the x-ray structures, protonation states are
frequently based simply on pH, which were 7.0 in this study.
However, in the case of GLIC there have been quite detailed
pKa calculations, and a number of studies with different
protonation states have resulted in similar dehydration
(35,36,38). This could point to other factors, such as a mem-
brane potential and ionic current through the channel,
becoming important to maintain hydration of the open state.
IVM binding has a direct influence on the 90 region,
where it allowed the channel to explore more open confor-
mations both around 90 and at the extracellular side, above
the 150 region where IVM is bound (Fig. 3 and Fig. S2).
Without IVM, the minimum radius of the pore occurred at
90 with an average of 1.2 5 0.2 A˚ (occasionally reaching
1.7 A˚), which is even slightly below the ELIC structure.
When IVMwas present, the minimum radius had an average
of 1.45 0.2 A˚ and periodically exceeded 2 A˚. Thus, regard-
less of hydration or dehydration, the tendency of the channel
to visit states that are slightly more open with IVM bound
appeared to be important, together with the behavior of
the rest of the pore domain.
Somewhat strikingly, the absence or presence of IVM in
the allosteric binding site in the TMD appeared to have a
significant effect on loop C in the ECD almost 40 A˚ away,
close to the neurotransmitter-binding site. With IVM bound,
loop C swung away from the ECD and partly lost its beta
sheet secondary structure, which appeared to lead to a
more open neurotransmitter-binding pocket. No change
was observed in the neurotransmitter binding pocket vol-
ume, but a disordered loop C exposed the pocket to the sur-
roundings. This correlates with the findings that loop C has
no direct effect on agonist selectivity, but it does affect the
efficiency (8–11); after agonist binding, through interactions
with the agonist itself, loop C might adopt a more rigid betaBiophysical Journal 105(3) 640–647
646 Yoluk et al.hairpin structure and thus help trap the agonist by isolating
the cavity from the environment. This agrees with previous
models where agonist binding was believed to change loop
C from uncapped to capped conformation (10). This type of
interaction could potentially also explain how some ligands
have double roles as both allosteric modulators and partial
agonists (12).
Out of the three H-bonds IVM makes in the x-ray struc-
ture, only one (to L218 backbone) was found to be present
throughout the simulations. On average, there was always
another H-bond formed too, but it alternated between the
residues Q219, S260, N264, and T285. This appears to agree
with findings of Lynagh et al. (39) who found that GlyR
could still be activated by IVM after the mutation S260I.
Nevertheless, this result does not rule out the importance
of S260, because homomeric GluClb (where residue 260
is Gln) is not activated by IVM (37). The GluClb result
might also be explained by a valine in position 218, if this
side chain affects the backbone flexibility.
In summary, GluCla likely remains one of the best cur-
rent templates for modeling and simulation of vertebrate
ligand-gated ion channels, in particular when the influence
of the IVM is taken into account and the structure is allowed
to relax without it. In contrast to the prokaryotic GLIC,
GluCl is both known to be activated by specific ligands
and has a behavior much more similar to GlyR and
GABAAR. These attributes should make it possible for
future simulations to investigate the entire path from neuro-
transmitter binding, to ECD influence on the TMD, to allo-
steric modulator binding, and eventual channel opening in
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